Hepatitis C Overview

<p>Immune globulin (D)</p> Signup and view all the answers

<p>Advancing age (C)</p> Signup and view all the answers

<p>Severe dehydration (B)</p> Signup and view all the answers

<p>HCV transmission by breastfeeding has not been documented. (D)</p> Signup and view all the answers

<p>Close monitoring and following published guidelines (B)</p> Signup and view all the answers

<p>Quantitative assays provide information on drug treatment regimens. (C)</p> Signup and view all the answers

<p>1.3% (C)</p> Signup and view all the answers

<p>To determine which antiviral agents should be used. (D)</p> Signup and view all the answers

<p>18 months (D)</p> Signup and view all the answers

<p>Young nonurban white individuals (B)</p> Signup and view all the answers

<p>Consider performing quantitative RNA tests as early as 1 to 2 months. (C)</p> Signup and view all the answers

<p>Maternal-fetal transmission (B)</p> Signup and view all the answers

<p>Clinical monitoring and potential enrollment in clinical trials. (B)</p> Signup and view all the answers

<p>1 in 2 million units (A)</p> Signup and view all the answers

<p>Northern Africa (D)</p> Signup and view all the answers

<p>They can have significant adverse reactions. (D)</p> Signup and view all the answers

<p>Interferon-free direct-acting antiviral drug regimens. (D)</p> Signup and view all the answers

<p>All of the above (D)</p> Signup and view all the answers

<p>Non-urban young white individuals (B)</p> Signup and view all the answers

<p>Serologic testing should be performed at 18 months. (B)</p> Signup and view all the answers

<p>Risk factors associated with behavior (B)</p> Signup and view all the answers

Measuring the presence or amount of Hepatitis C virus RNA in a sample.

Assays that measure the concentration of HCV RNA.

Identifying the specific type (genotype) of HCV.

Strategies used to treat Hepatitis C infection.

HCV infection acquired during childbirth.

Blood test for antibodies against HCV.

Drugs that specifically target HCV.

Tracking a patient's HCV infection for treatment and monitoring.

Chronic HCV infection in children can progress faster if they have other health conditions like HIV, cancer, iron overload, or thalassemia.

Chronic HCV infection significantly increases the risk of liver damage, cirrhosis, and liver cancer, especially with age.

Patients with chronic HCV infection should get vaccinated for hepatitis A and B, due to a high risk of severe hepatitis.

Children with HCV should be closely monitored, including tracking alanine transaminase (ALT) levels, to detect and manage possible liver disease progression.

Chronic HCV infection increases the risk of liver complications (cirrhosis and liver cancer) in adults as they age.

Co-occurring infections, alcohol use, and specific medications (like acetaminophen or antiretrovirals) can worsen HCV-related liver disease in patients.

Evidence-based guidelines for screening, treatment, and managing HCV infection are available online.

Mothers with HCV infection can breastfeed safely. Transmission through breastfeeding is not documented.

Estimated at 1.3% of general population, equating to 3.5 million with chronic infection.

Injection drug use or blood products before 1992 are most common risk factors.

Maternal-fetal transmission is the most common route.

Extremely low, estimated at less than 1 case per 2 million units.

A significant risk factor, as approximately 60% of reported acute cases are linked to injection drug users.

Concentrated in northern Africa, the Middle East, and parts of Asia.

Primarily through percutaneous (parenteral) exposures to infected blood.

Mostly found in white, nonurban, young people with a history of injection drug use and opioid use.